Medable startup lands $91M to revamp clinical trials

Business : Medable, a startup aiming to revamp the way clinical trials are performed, raised $91 million in a Series C funding round led by Sapphire Ventures. The Palo Alto based company aims to reduce clinical trial timelines by 50 percent through its decentralized trial platform.

More News :

The adoption of telemedicine services during the global pandemic has trickled down from humans to our four-legged friends. Swedish startup FirstVet is expanding its video veterinary consultation platform in the United States after securing a $35 million financing round led by Mubadala Capital.

Heyday, a startup focused on building online consumer brands, raised $175 million in a Series A round backed by General Catalyst, Khosla Ventures and Arbor Ventures. The San Francisco-based company partners with entrepreneurs to acquire, launch and incubate brands.

Boston-based Zapata Computing, a developer of quantum computing software, closed a $31 million Series B round led by Comcast Ventures, Pitango and Prelude Ventures.

The company’s platform allows enterprises to improve data and workflows on current high-performance computers, with the capability to eventually move to commercial quantum computing.